Organism: Homo sapiens
Gene: 39629_at
Selected probe(set): 215870_s_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array

Expression of 39629_at (215870_s_at) across 6674 perturbations tested by GENEVESTIGATOR:

Relative Expression (log2-ratio):-5.9797354
Number of Samples:2 / 2

Experimental	CNS cancer study 1 (PDX; glioma, malignant, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary glioma, malignant, NOS of the central nervous system (subcutaneously implanted).
Control	CNS cancer study 1 (PDX; ependymoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary ependymoma, NOS of the central nervous system (subcutaneously implanted).

Relative Expression (log2-ratio):-3.8541622
Number of Samples:3 / 2

Experimental	CNS cancer study 1 (PDX; glioblastoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary glioblastoma, NOS of the central nervous system (subcutaneously implanted).
Control	CNS cancer study 1 (PDX; ependymoma, NOS; primary)
	Patient-derived xenograft (PDX) samples generated in female athymic nude mice from patients with primary ependymoma, NOS of the central nervous system (subcutaneously implanted).

Relative Expression (log2-ratio):3.7640667
Number of Samples:3 / 3

Experimental	AM580 study 1
	Monocytes were cultured for 5 days with 500 U/ml IL-4 and 800 U/ml GM-CSF, cytokine treatment was repeated at day 3. AM580 (AM; 100 nM) was added at the beginning of differentiation. ATC code:---
Control	vehicle (DMSO/EtOH)/ IL-4/ GM-CSF treated monocyte sample
	Monocytes were cultured for 5 days with 500 U/ml IL-4 and 800 U/ml GM-CSF, cytokine treatment was repeated at day 3. Vehicle (DMSO/ethanol) was added at the beginning of differentiation.

Relative Expression (log2-ratio):3.6986494
Number of Samples:3 / 6

Experimental	human AB serum study 1 (late)
	Monocytes, cultured in RPMI medium containing 10% human AB serum (HS) instead of FBS, and 500 U/ml IL-4 and 800 U/ml GM-CSF for 5 days. Cytokine treatment was repeated at day 3.
Control	IL-4; GM-CSF study 1 (late)
	Monocytes, cultured with vehicle (DMSO/ethanol) and 500 U/ml IL-4 and 800 U/ml GM-CSF for 5 days. Cytokine treatment was repeated at day 3.

Relative Expression (log2-ratio):3.30272
Number of Samples:2 / 6

Experimental	retina pigment epithelium study 1 (adult)
	Postmortem human native retina pigment epithelium samples from adult individuals.
Control	retina pigment epithelium study 1 (fetal)
	Human native fetal retina pigment epithelium samples obtained at gestation age between week 16-18.

Relative Expression (log2-ratio):-3.296321
Number of Samples:3 / 5

Experimental	prostate cancer study 8 (p. canc)
	CD26+ FACS sorted prostate neoplasm cell (p. canc) samples from patients with primary prostate cancer collected after radical prostatectomy.
Control	prostate cancer study 8 (psfmc)
	CD49a+ FACS sorted prostate stromal fibromuscular cell (psfmc) samples from patients with primary prostate cancer collected after radical prostatectomy.

Relative Expression (log2-ratio):3.2047882
Number of Samples:10 / 10

Experimental	endometriosis study 2
	Endometrium tissue from patients with endometriosis.
Control	normal endometrium tissue
	Normal endometrium tissue.

Relative Expression (log2-ratio):3.1788054
Number of Samples:2 / 2

Experimental	osteoarthritis study 3
	Osteocytes/-blasts in P2 from human bone chips from patients with osteoarthritis.
Control	normal chondrocyte sample
	Healthy chondrocytes.

Relative Expression (log2-ratio):-2.9775848
Number of Samples:22 / 34

Experimental	brain tumor study 1 (medulloblastoma)
	Primary tumor tissue sample from the brain of patients with medulloblastoma.
Control	brain tumor study 1 (glioblastoma)
	Primary tumor tissue sample from the brain of patients with glioblastoma multiformae.

Relative Expression (log2-ratio):2.949957
Number of Samples:18 / 23

Experimental	endometriosis study 1
	Endometrium and ovary tissue from patients with endometriosis.
Control	normal endometrium tissue
	Normal endometrium tissue.